首页> 中文期刊> 《中华医学杂志(英文版) 》 >Analysis of Gram-positive bacterial infection in patients following liver transplantation

Analysis of Gram-positive bacterial infection in patients following liver transplantation

         

摘要

Background Liver transplantation is the most effective treatment for patients with end-stage liver failure,however infection after transplantation is a serious clinical complication.The purpose of this research was to investigate the molecular epidemiology and the influence of multidrug-resistant Gram-positive infection in patients,following liver transplantation,to provide reference for clinical treatment and prevention of Gram-positive bacterial infection.Methods We isolated and detected bacteria from phlegm,throat swabs,urine,wound or wound secretions,blood,and fecal samples from 221 liver transplant patients in our hospital from January 2007 to April 2010.All isolated bacterial strains were identified and tested by minimal inhibitory concentration (MIC) drug-sensitive detection using the BioMerieux ATB bacterial identification instrument and repetitive extragenic palindromic-polymerase chain reaction (REP-PCR)detection of bacterial homology.Risk factors were calculated by multivariate Logistic regression analysis.Results We collected 250 specimens from 221 patients hospitalized following liver transplantation surgery,of which 29patients developed multiple infections.Sixty-five Gram-positive bacterial strains were isolated from different specimens from 53 infectious patients.We detected 29 multidrug-resistant Gram-positive strains from 29 patients (44.62%),including 20 Staphylococcus aureus (S.aureus) strains (68.97%) and nine Enterococcus strains (31.03%).All 20 S.aureus strains were highly resistant to aminoglycosides (gentamicin),cephalosporins (cefoxitin),quinolones (ciprofloxacin and levofloxacin),lincomycins (clindamycin),penicillin,and erythromycin.The resistance rate reached 100% in some cases.The S.aureus strains were highly sensitive to vancomycin and oxazolidinone (linezolid),with MIC50 <2 μg/ml for both.The nine Enterococci strains were also highly resistant to aminoglycosides,quinolones,and penicillins,and highly sensitive to vancomycin (MIC50 <2 μg/ml) and oxazolidinone (MIC50 <1μg/ml).Using REP-PCR detection,S.aureus was divided into five genotypes with 14 B-type strains.Enterococcus was divided into 11 genotypes,with two D-type strains,two G-type strains,and two K-type strains.The risk factors for Gram-positive bacterial infection in patients following liver transplantation were preoperative use of antibiotics (OR=3.949,P=0.004),high intra-operative blood input (OR=1.071,P=0.005),and postoperative renal failure (OR=5.427,P=0.043).Conclusions S.aureus and Enterococcus were the main pathogens causing infection following liver transplantation in patients with drug-resistant Gram-positive bacterial infection.The isolated strains were resistant to multiple antibiotics.B-type S.aureus strains were predominant.Reasonable use of antibiotics,decreasing intra-operative blood input,and preventing post-operative renal failure may reduce Gram-positive bacterial infections and the appearance of drug-resistant strains following liver transplantation.

著录项

  • 来源
    《中华医学杂志(英文版) 》 |2012年第14期|2417-2421|共5页
  • 作者单位

    Department of Hepatobiliary Surgery, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, China;

    Shandong University School of Medicine, Jinan, Shandong 250061, China;

    Department of Hepatobiliary Surgery, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, China;

    Department of Hepatobiliary Surgery, Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China;

    Department of Hepatobiliary Surgery, Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China;

    Department of Hepatobiliary Surgery, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号